References
- Lowe NJ, Ascher B, Heckmann M, Kumar C, Fraczek S, Eadie N. BotoxFacial Aesthetics Study Team. Double-blind, randomised placebo- controlled dose – response study of the safety and efficiency of Botulinum Toxin type A in subjects with crows feet. Dermatol Surg. 2005;31:257–262.
- Lee GA. use of AccuveinTM for preventing complication from accidental vein puncture when administering dermal filler injections. J Cos Las Ther. 2015;17:55–56.
- Aulagnier J, Hoc C, Mathieu E. Efficiency of Accuvein to facilitate peripheral intravenous placement in adults presenting to an emergency department: a randomised clinical trial. Acad Emerg Med. 2014;21:858–863.
- Miyake RK, Zeman HD, Duate FH, Kikuchi R. Vein imaging: a new method of near infrared imaging. Dermatol Surg. 2006; 32:1031–1038.
- Highton L. Use of the Accuvein device to map the superficial venous system. Eur J Plast Surg. 2011;34:305–306.
- Lowe NL, Lask G, Yamauche P, Moore D. Bilateral double blind randomised comparison of 3 dose of botulinum toxin type A and placebo in patients with crows feet. J Am Acad Dermatol. 2002;47:834–840.
- Carruthers JA, Lowe NJ, Menter MA, Gibson J, Nordquist M, Mordaunt J, et al. A multicentre, double blind randomised, placebo controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002;46:840–849.
- Bluegerman G, Schavelzon D, Alvarez J. Near-infrared imaging of veins in facial injection of botulinum toxin and hyaluronic acid. J Derm Surg. 2012;38:1252–1253.